Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2012
09/26/2012CN101822749B Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof
09/26/2012CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
09/26/2012CN101756925B Glipizide long-acting slow-release preparation and preparation method thereof
09/26/2012CN101610760B Treatment of cachexia
09/26/2012CN101420943B Chewing composition containing coenzyme q10
09/26/2012CN101389339B Therapeutic agent for diabetes
09/26/2012CN101332303B Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing blood glp-1 level
09/26/2012CN101128485B Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4)
09/26/2012CN101103983B Medicinal composition stabilized by base reagent containing pitavastatin calcium and preparation technology thereof
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273854 GLP-1 analog fusion proteins
09/25/2012US8273734 5HT2C receptor modulators
09/25/2012US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/25/2012US8273717 Inhibitor for perioperative blood sugar elevation
09/25/2012US8273713 Dietetics, eating disorders, antidiabetic agents
09/25/2012US8273350 Antibodies to human IL-1β
09/25/2012CA2771537A1 Composition, synthesis, and use of new substituted pyran and pterin compounds
09/25/2012CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
09/25/2012CA2554679C Prophylactic or therapeutic agent for diabetic maculopathy
09/25/2012CA2516822C Method for preparing acid addition salts of polyacidic basic compound
09/25/2012CA2496688C Glycinamide derivatives as raf-kinase inhibitors
09/25/2012CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/20/2012WO2012125830A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012WO2012125622A1 Substituted adipic acid amides and uses thereof
09/20/2012WO2012125182A1 Npp1 fusion proteins
09/20/2012WO2012124888A2 Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathy
09/20/2012WO2012124817A1 Sprouted cereal, method for manufacturing same, food product containing same, and bdnf production accelerator
09/20/2012WO2012124744A1 Nitrogen-containing condensed heterocyclic compound
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124311A1 Novel phenylpyridine derivative and drug containing same
09/20/2012WO2012123468A1 New azaspirodecanone compounds
09/20/2012WO2012123449A1 N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators
09/20/2012WO2012123432A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
09/20/2012WO2012122860A1 Human insulin and analog conjugate thereof
09/20/2012WO2012122707A1 Quaternary ammonium salt compounds, preparation method, pharmaceutical composition and use thereof
09/20/2012WO2012097429A8 Probiotic soft gel compositions
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238623 Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
09/20/2012US20120238613 Sec-hydroxycyclohexyl derivatives
09/20/2012US20120238611 Dual-acting benzoimidazole antihypertensive agents
09/20/2012US20120238594 Azaspirodecanone compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238581 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
09/20/2012US20120238574 (1, 1, 1,3,3,3 -hexafluoro-2 hydroxypropan- 2 -yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238563 Novel unsaturated tetracyclic tetrahydrofuran derivatives
09/20/2012US20120238554 Salts of potassium atp channel openers and uses thereof
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238537 Synthetic bile acid compositions and methods
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238522 Carotenoid-containing compositions and methods
09/20/2012US20120238514 Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
09/20/2012US20120238510 Crystalline form of benzylbenzene sglt2 inhibitor
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238506 Acacia macrostachya seed extract and compositions containing same
09/20/2012US20120238497 Glp-1 fusion peptides, their production and use
09/20/2012US20120238496 Fusion protein regulating plasma glucose and lipid, its preparation method and use
09/20/2012US20120238493 Glucagon analogs exhibiting gip receptor activity
09/20/2012US20120238492 Fish protein hydrolysate for the use thereof in inhibiting weight gain and/or weight loss
09/20/2012US20120238490 Methods and compositions for the treatment of metabolic disorders
09/20/2012US20120237628 Composition for promoting health of cardiovascular system
09/20/2012US20120237625 Metabolism accelerating composition comprising astragali radix extract
09/20/2012US20120237624 Vigna unguiculata seed extract and compositions containing same
09/20/2012US20120237622 Herbal milk replacer compositions for calf
09/20/2012US20120237617 Use of nitrite salts in treating tissue damage
09/20/2012US20120237599 Enterically coated cysteamine, cystamine and derivatives thereof
09/20/2012US20120237594 Methods of treating hypertriglyceridemia
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237472 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012US20120234721 Diuretic and diuretic-like compound analogs
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830126A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
09/20/2012CA2830115A1 New azaspirodecanone compounds
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829947A1 Dosing regimens for the treatment of fabry disease
09/20/2012CA2829767A1 Npp1 fusion proteins
09/19/2012EP2500347A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
09/19/2012EP2500345A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative
09/19/2012EP2500020A1 Therapeutic or prophylactic agent for diabetes
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499139A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2498802A1 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
09/19/2012EP2498801A1 Pharmaceutical composition comprising a glp-1 agonist and methionine
09/19/2012EP2498794A1 Method of treatment of type 2 diabetes
09/19/2012EP2498779A1 Pemirolast for the treatment of systemic low grade inflammation
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1298